Neomycin: Clinical Trials

37 trials of Neomycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 9 unknown, 3 active not recruiting, 3 recruiting. 11 Not applicable, 8 Phase 2, 7 Phase 4, 4 Early Phase 1, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 9, Unknown 2
Phase 28Completed 2, Unknown 2, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 47Completed 2, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Early Phase 14Active not recruiting 1, Completed 1, Terminated 1, Unknown 1
Phase 13Completed 2, Recruiting 1
Phase 32Unknown 2

Follow Neomycin: new trials by email Literature Review of Neomycin trials Research Report on Neomycin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon Surgery
Rifaximin (Xifaxan), Metronidazole, Neomycin Sulfate - Surgical Site Infection, Colon Surgery
Phase 4Not yet recruitingUniversität Luzern4582026-06-012025-09-18
Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure
MTP-101-C encapsulated Microbiota, Vancomycin, Neomycin - Chronic Heart Failure
Phase 1RecruitingMelana Yuzefpolskaya, MD402025-10-202026-10-08
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Vancomycin, Neomycin and MTT capsules, Placebo capsules - Alopecia Areata, Alopecia Totalis
Phase 2RecruitingUniversity of Minnesota402025-08-212026-06-26
The Safety and Microbial Changes in the Use of Intranasal Neosporin®
Intranasal application of Polymyxin B Sulfate 500,000 IU, Bacitracin zinc 40,000 IU, Neomycin Sulfate 0.35g neomycin base - Teste the Safety of (Polymyxin B Sulfate 500,000 IU, Bacitracin Zinc 40,000 IU, Neomycin Sulfate 0.35g Neomycin Base) Intranasally
Not applicableCompletedHospital Universitario Dr. Jose E. Gonzalez122025-02-132026-07-14
Do Topical Antibiotics Improve Skin Graft Results?
Neomycin - Skin Transplantation, Wounds and Injuries
CompletedLAMB Project1422024-12-012025-12-16
Antibiotics and Vaccine Immune Responses Study
BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule - Vaccine Response Impaired
Phase 4RecruitingSouth Australian Health and Medical Research Institute3482023-11-232026-09-17
SURGIcal COmplication and MIcrobiome ChangeS in Colorectal Surgery
Neomycin Sulfate - Anastomotic Leak, Microbial Colonization
UnknownUzsoki Hospital1002023-02-012023-03-22
Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis
Neomycin/ Dexameythasone/Xylometazoline, Bacillus subtilis DSM32444 - Rhinosinusitis, Rhinitis
Not applicableCompletedHuro Biotech Joint Stock Company602022-12-292024-03-05
Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin
Neomycin - Colonization, Asymptomatic
Phase 4UnknownMahidol University602022-11-242022-11-30
Bowel Preparation in Elective Pediatric Colorectal Surgery
Senna, Sodium Picosulfate, Magnesium Oxide and Citric Acid, Metronidazole Oral - Colostomy, Hirschsprung Disease - Pull Through
Not applicableUnknownMcMaster University812022-01-012021-12-09
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
Biopsy, Fecal Microbiota Transplantation, Fecal Microbiota Transplantation Capsule - Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma
Phase 2Active not recruitingM.D. Anderson Cancer Center152021-02-222026-06-12
Prophylatic Effect Preoperative Antibiotics With Mechanical Bowel Preparation in SSIs
Neomycin,metronidazole - Surgical Site Infection, Postoperative Complications
Not applicableCompletedThird Affiliated Hospital, Sun Yat-Sen University3092019-01-172023-04-05
Comparing No Mechanical Bowel Preparation With Oral Antibiotics Alone in Patients Undergoing Elective Colon Surgery
No Preparation, Neomycin and Flagyl - Elective Colon Surgery
Phase 4Active not recruitingOttawa Hospital Research Institute6302018-10-232026-06-16
Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
Vancomycin, Neomycin, Ciprofloxacin - Crohn Disease
Phase 2CompletedChildren's Hospital of Philadelphia102018-07-122022-02-09
Responses to Rabies Vaccine in Adults With or Without Antibiotics
Rabies Vaccine, Metronidazole, Vancomycin - Rabies Human
Phase 4CompletedEmory University372018-07-052023-06-08
Serial Endoscopic Surveillance & Direct Topical Antibiotics to Define the Role of Microbes in Anastomotic Healing
Cipro, metronidazole, neomycin combo, Serial Endoscopic Surveillance, Saline - Anastomotic Leak, Rectal Cancer
Phase 2WithdrawnUniversity of Chicago2017-03-032023-04-26
Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis
Fecal Microbiota Transplantation (FMT), OpenBiome, pretreatment antibiotics - Ulcerative Colitis
Phase 1CompletedNajwa Elnachef302017-03-022021-04-28
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
Polyethylene Glycol, Neomycin, Metronidazole Hydrochloride - Colorectal Neoplasms, Diverticulitis
Early Phase 1UnknownThomas Jefferson University2242016-09-012018-08-22
Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
Fluconazole, Vancomycin, Neomycin - Crohn's Disease
Phase 2CompletedUniversity of Pennsylvania82016-08-012024-02-06
Interventional Bioremediation of Microbiota in Metabolic Syndrome
Vancomycin, Placebo, Neomycin - Pre-Diabetes
Phase 2TerminatedUniversity of Minnesota122016-06-012023-02-22

Showing 20 of 37. Sign in to see all of them.

Conditions studied

Surgical Wound Infection (5)  ·  Colorectal Neoplasms (3)  ·  Anastomotic Leak (2)  ·  Colitis, Ulcerative (2)  ·  Crohn Disease (2)  ·  Diabetes Mellitus (2)  ·  Inflammatory Bowel Diseases (2)  ·  Alopecia Areata (1)  ·  Alopecia universalis (1)  ·  Asymptomatic Infections (1)  ·  Bacteremia (1)  ·  Biliary Atresia (1)  ·  Blind Loop Syndrome (1)  ·  Cholangitis (1)  ·  Communicable Diseases (1)

Sponsors

Emory University (2)  ·  University of Minnesota (2)  ·  Bayer (1)  ·  Cedars-Sinai Medical Center (1)  ·  Children's Hospital of Philadelphia (1)  ·  Chulalongkorn University (1)  ·  Helsinki University Central Hospital (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)  ·  Huro Biotech Joint Stock Company (1)  ·  Julio Ramirez (1)  ·  LAMB Project (1)  ·  Laboratoire Innotech International (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mahidol University (1)  ·  Maimónides Biomedical Research Institute of Córdoba (1)

Countries

United States (15)  ·  Israel (2)  ·  Switzerland (2)  ·  Thailand (2)  ·  Australia (1)  ·  Bangladesh (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Mexico (1)  ·  Netherlands (1)

Top investigators

Lindsey Albenberg, DO (2)  ·  Nadine Rouphael, MD (2)  ·  Adhiratha Boonyasiri, MD (1)  ·  Adrian Camacho Ortiz, MD, PhD (1)  ·  Alexander Khoruts, MD (1)  ·  Benjamin Phillips, MD (1)  ·  Carlos A Caramori (1)  ·  David Lynn (1)  ·  David Seligson, MD (1)  ·  Fernando G Romeiro (1)  ·  George T Macfarlane, BSCc, PHD (1)  ·  Hongbo Wei, Ph.D (1)  ·  James D Lewis, MD, MSCE (1)  ·  Jean Marc Bohbot (1)

Results publications

PMID 36748942, PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 25534776, PMID 27494911, PMID 30530985, PMID 30616014, PMID 31402112, PMID 31954100, PMID 34174187, PMID 35365713, PMID 37702427, PMID 38796500, PMID 4902833, PMID 8948280

NIH funding

2014 (1), 2025 (1), K23DK109136 (1), P50CA221707 (1)